Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2022 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
NERV on Nasdaq
Shares outstanding
45,675,986
Price per share
$4.07
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
23,063,409
Total reported value
$90,576,655
% of total 13F portfolios
0%
Share change
+19,428,234
Value change
+$76,545,252
Number of holders
29
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FEDERATED HERMES, INC. 20% +2.8% $35,502,800 +$30,394,980 9,392,275 +595% Federated Hermes, Inc. 22 Dec 2025
Vivo Opportunity Fund Holdings, L.P. 10% $32,476,142 8,591,572 Vivo Opportunity Fund Holdings, L.P. 23 Dec 2025
Coastlands Capital LP 10% $18,571,536 4,563,031 Coastlands Capital LP 13 Feb 2026
Farallon Capital Partners, L.P. 10% 0% $18,250,213 4,539,854 0% Dapice Joshua J. 31 Dec 2025
Logos Global Management LP 9.9% $18,407,093 4,435,444 Logos Global Management LP 23 Dec 2025
BALYASNY ASSET MANAGEMENT L.P. 10% $17,970,807 4,330,315 Balyasny Asset Management L.P. 31 Dec 2025
Adage Capital Management, L.P. 6.4% $11,777,700 2,838,000 Adage Capital Management, L.P. 31 Dec 2025

As of 31 Dec 2025, 29 institutional investors reported holding 23,063,409 shares of Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV). This represents 50% of the company’s total 45,675,986 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) together control 50% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FEDERATED HERMES, INC. 12% 5,371,775 +298% 0.03% $19,456,450
Vivo Capital, LLC 9.5% 4,322,747 1.1% $17,377,443
Logos Global Management LP 7.2% 3,311,000 0.89% $13,310,220
ADAGE CAPITAL PARTNERS GP, L.L.C. 6.2% 2,838,000 0.02% $11,408,760
FARALLON CAPITAL MANAGEMENT LLC 5.2% 2,365,000 0.05% $9,507,300
Ally Bridge Group (NY) LLC 3.6% 1,655,500 11% $6,655,110
Spruce Street Capital LP 3.6% 1,655,500 0% 2.2% $6,655,110
ACUTA CAPITAL PARTNERS, LLC 1.6% 709,500 1.9% $2,852,190
VANGUARD GROUP INC 0.55% 252,029 0% 0% $1,013,156
RENAISSANCE TECHNOLOGIES LLC 0.33% 149,200 +28% 0% $599,784
MILLENNIUM MANAGEMENT LLC 0.3% 137,911 0% $554,402
BlackRock, Inc. 0.16% 72,669 0% 0% $292,129
GEODE CAPITAL MANAGEMENT, LLC 0.15% 69,919 -7.5% 0% $281,133
Apella Capital, LLC 0.09% 42,380 +7.8% 0% $170,368
Lion Point Capital, LP 0.08% 35,000 0.73% $140,700
STATE STREET CORP 0.05% 24,019 +45% 0% $96,556
TWO SIGMA INVESTMENTS, LP 0.05% 22,294 0% $89,622
MORGAN STANLEY 0.02% 11,055 +0.43% 0% $44,441
ACADIAN ASSET MANAGEMENT LLC 0.02% 10,579 -39% 0% $42,000
ROYAL BANK OF CANADA 0% 2,240 -7.8% 0% $9,000
UBS Group AG 0% 1,807 +17970% 0% $7,264
DEUTSCHE BANK AG\ 0% 1,500 0% $6,030
Tower Research Capital LLC (TRC) 0% 501 -63% 0% $2,014
CWM, LLC 0% 420 0% 0% $2,000
Larson Financial Group LLC 0% 400 0% $1,608

Institutional Holders of Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 23,063,409 $90,576,655 +$76,545,252 $4.02 29
2025 Q3 1,979,675 $4,208,645 +$81,860 $2.10 22
2025 Q2 1,944,466 $3,341,879 -$12,369 $1.72 18
2025 Q1 1,951,817 $3,310,087 -$310,831 $1.70 19
2024 Q4 2,085,897 $4,630,050 -$81,975 $2.22 21
2024 Q3 2,118,026 $5,654,665 +$83,536 $2.67 19
2024 Q2 2,086,302 $6,654,936 -$42,908 $3.19 20
2024 Q1 2,099,790 $5,416,495 -$2,569,915 $2.58 20
2023 Q4 2,415,482 $14,854,825 +$68,371 $6.15 19
2023 Q3 2,403,051 $16,580,809 +$303,012 $6.90 19
2023 Q2 2,352,300 $19,044,605 +$5,865,507 $9.14 18
2023 Q1 1,680,901 $2,687,500 -$78,110 $1.60 14
2022 Q4 1,729,786 $2,748,707 -$3,027,635 $1.59 17
2022 Q3 2,028,914 $18,733,000 -$1,898,373 $9.24 23
2022 Q2 2,269,165 $7,508,000 +$7,508,000 $3.31 20